BRIEF published on 10/21/2025 at 07:05, 10 months 12 days ago Edenred : Croissance Accélérée au Troisième Trimestre 2025 Edenred Chiffre D'affaires Croissance EBITDA Partenariats Stratégiques
BRIEF published on 10/21/2025 at 07:05, 10 months 12 days ago Edenred Sees Growth Acceleration in Q3 2025 Strategic Partnerships 2025 Targets Edenred Revenue Growth Third-quarter Performance Mobility And Meal Vouchers
BRIEF published on 10/21/2025 at 07:05, 10 months 12 days ago Interparfums : Croissance modérée au troisième trimestre 2025 Chiffre D'affaires Interparfums Croissance Économique Marchés Géographiques Parfums Jimmy Choo
BRIEF published on 10/21/2025 at 07:05, 10 months 12 days ago Interparfums Reports Positive Nine-Month Sales in 2025 Geopolitical Impact North America Market Interparfums Sales Jimmy Choo Growth Lacoste Fragrances
BRIEF published on 10/21/2025 at 06:50, 10 months 12 days ago HUBER+SUHNER Sees Strong Order Intake Growth in First Nine Months of 2025 Order Intake Growth Sales Outlook Industry Segment Communication Segment Transportation Stability
BRIEF published on 10/21/2025 at 06:50, 10 months 12 days ago HUBER+SUHNER enregistre une forte croissance de ses commandes au cours des neuf premiers mois de 2025 Croissance Des Prises De Commandes Secteur D'activité Segment De Communication Stabilité Des Transports Perspectives De Ventes
BRIEF published on 10/21/2025 at 06:37, 10 months 12 days ago Getlink Reports Solid Q3 2025 Revenue Revenue Growth Getlink ElecLink Eurotunnel Q3 2025
BRIEF published on 10/21/2025 at 06:37, 10 months 12 days ago Getlink annonce un chiffre d'affaires solide au troisième trimestre 2025 Croissance Des Revenus ElecLink Obtenir Un Lien Eurotunnel T3 2025
BRIEF published on 10/21/2025 at 06:35, 10 months 12 days ago Formycon Launches Europe’s First Ranibizumab Biosimilar in Pre-filled Syringe Teva Pharmaceuticals Ranibizumab Biosimilar Pre-filled Syringe FYB201/Ranivisio® Formycon Launch
BRIEF published on 10/21/2025 at 06:35, 10 months 12 days ago Formycon lance le premier biosimilaire du ranibizumab en seringue préremplie en Europe Teva Pharmaceuticals FYB201/Ranivisio® Biosimilaire Du Ranibizumab Seringue Préremplie Lancement De Formycon
Published on 09/02/2026 at 22:55, 4 hours 58 minutes ago Secure Blockchain Sells Delivery Trust(R) Business
Published on 09/02/2026 at 18:45, 9 hours 8 minutes ago Full Circle Lithium Rebrands as FCL-X Fire & Safety Inc. and Provides Corporate Update
Published on 09/02/2026 at 15:00, 12 hours 53 minutes ago Vox Royalty Enters into Binding Agreement to Acquire the White Dam Gold Royalty in Australia
Published on 09/02/2026 at 14:30, 13 hours 23 minutes ago Solitario Completes Phase-One Drilling at Golden Crest - Reports Initial Drill Results for Ponderosa
Published on 09/02/2026 at 14:00, 13 hours 53 minutes ago Orogen Royalties Acquires Two Gold Projects in Southwest Utah
Published on 09/03/2026 at 02:55, 57 minutes ago STRATEGIC PARTNERSHIP WITH CARESTER FOR OXIDE SEPARATION DEVELOPMENT AND 10-YEAR OFFTAKE AGREEMENT
Published on 09/03/2026 at 01:05, 2 hours 47 minutes ago The Royal Mint Boldly Goes Where No Coin Has Gone Before With New Star Trek 50p Coins
Published on 09/02/2026 at 23:55, 3 hours 57 minutes ago Positive Preliminary Feasibility Study (PFS) outlines Vulcan’s second German project showcasing repeatable development growth strategy
Published on 09/02/2026 at 23:45, 4 hours 7 minutes ago EQS-Adhoc: Vulcan Energy Resources Limited: Positive Preliminary Feasibility Study (PFS) outlines Vulcan’s second German project showcasing repeatable development growth strategy
Published on 09/02/2026 at 19:50, 8 hours 2 minutes ago Cotecna Strengthens Food Testing Capabilities in India with Geo-Chem's New Food Safety Laboratory in Navi Mumbai, India
Published on 09/02/2026 at 21:30, 6 hours 23 minutes ago Accor announces the success of OCEANEs due 2032 for a nominal amount of €380 million and the results of the partial repurchase of its outstanding OCEANEs due 2027
Published on 09/02/2026 at 21:30, 6 hours 23 minutes ago Accor annonce le succès d'OCEANEs à échéance 2032 pour un montant nominal de 380 millions d’euros et les résultats du rachat partiel de ses OCEANEs en circulation à échéance 2027
Published on 09/02/2026 at 19:03, 8 hours 49 minutes ago Communiqué au dépôt du projet de note d'information établi par Bourrelier Group
Published on 09/02/2026 at 18:20, 9 hours 32 minutes ago Appointment to Edenred’s Executive Committee
